Scientific Advisors
We have recruited a team of leading and well-respected physicians to provide medical advice and drug development insight.

Brian Berman, MD, PhD
Antiviral Advisor
Dr. Brian Berman is professor emeritus of dermatology and cutaneous surgery at the University of Miami Miller School of Medicine. He is vice president of both the American Academy of Dermatology and the American Academy of Dermatology Association, and vice president of the American Dermatological Association. He has held many leadership positions including vice chairman of the Department of Dermatology at The University of California, Davis and chairman of the Department of Dermatology at Mount Sinai Medical Center of Florida in Miami Beach. He is past president and founder of the National Association of Veterans Affairs Dermatologists and chaired the Dermatology Field Advisory Group for the Department of Veterans Affairs. He also serves on numerous scientific advisory/editorial boards, including the European Journal of Dermatology and the Journal of Clinical and Aesthetic Dermatology.
In addition to caring for patients at Skin and Cancer Associates in Aventura, Florida, Dr. Berman teaches at the Miami Veterans Affairs Medical Center. He also serves as co-director of the Center for Clinical and Cosmetic Research, where he continues his broad-based clinical research program while focusing laboratory investigations on the study of the control of scarring. He has presented at more than 300 dermatologic societies and meetings and has authored more than 250 peer-reviewed scientific and clinical articles, chapters, and books. He is the recipient of the Dean’s Senior Faculty Clinical Research Award from UMMSM, was bestowed the “Scientist of the Year” Award from Sigma Xi, a Science and Research Honor Society, and is included in U.S. News and World Report’s “Best Doctors in America.”

Diane Thiboutot, MD
Acne Advisor
Dr. Diane Thiboutot is a board-certified dermatologist who graduated from Penn State College of Medicine and completed her Residency in Dermatology at Penn State Milton S. Hershey Medical Center. She is currently Director of Clinical and Transitional Science Research Education, Professor of Dermatology, and Vice-Chair for Research for Dermatology at Pennsylvania State University College of Medicine in Hershey, PA.
Dr. Thiboutot and her team are continuously conducting mild, moderate and/or severe acne vulgaris studies to enhance the treatment options for teens and adults who suffer from acne. The studies have involved several combinations of investigational and/or FDA approved topical and/or oral medication. Additionally, her clinical trials office has fully executed research studies applying topical and oral medications, both Investigational and FDA approved products, for rosacea.
She is Co-Director of the Penn State MD/PhD program. Dr. Thiboutot is a reviewer for the National Institute of Health as well as several dermatology journals. She directs an active basic and clinical research program with the support from the NIH and sponsorship from large and small pharmaceutical firms as an independent clinical/scientific consultant. She is a member of the AOA Honor Medical Society She is a member of the AOA Honor Medical Society She is a member of the AOA Honor Medical Society.

Eric Simpson, MD
Inflammatory Skin Disease Advisor
Dr. Simpson’s collaborations are global in scope and has been invited to present his research and approach to patient care at international conferences in Europe, North and South America, and Asia. He has published over 80 scientific articles in several high-impact peer-reviewed journals including the New England Journal of Medicine and The Lancet. Dr. Simpson supports patient advocacy by serving as the Co-Chair of the Scientific Advisory Committee for the National Eczema Association. He also serves on the Executive Committee of the Harmonizing Outcome Measures in Eczema (HOME)- a volunteer group of patients, providers, and other stakeholders whose mission is to improve the quality of eczema research to better suit the needs of patients and policy-makers.